- Home
- GOVX vs HSCS Comparison
GOVX vs HSCS Comparison
Compare GOVX & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GOVX | HSCS |
|---|---|---|
| Founded | 2001 | 2007 |
| Country | United States | United States |
| Employees | 17 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2M | 8.2M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | GOVX | HSCS |
|---|---|---|
| Price | $0.22 | $3.05 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $7.00 | ★ $9.20 |
| AVG Volume (30 Days) | ★ 4.1M | 76.3K |
| Earning Date | 11-13-2025 | 12-15-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $3,353,560.00 | $8,669.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 8.52 | N/A |
| 52 Week Low | $0.12 | $2.01 |
| 52 Week High | $2.71 | $6.47 |
Technical Indicators
Market Signals| Indicator | GOVX | HSCS |
|---|---|---|
| Relative Strength Index (RSI) | 39.34 | 57.98 |
| Support Level | $0.16 | $2.95 |
| Resistance Level | $0.21 | $3.21 |
| Average True Range (ATR) | 0.04 | 0.22 |
| MACD | 0.01 | 0.08 |
| Stochastic Oscillator | 46.55 | 77.69 |
Price Performance
Historical ComparisonAbout GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.